+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Infection Surveillance Solutions Market, By Product vs. Service, By Infection Type, By End User, By Region, Competition, Forecast & Opportunities, 2014- 2025

  • PDF Icon

    Report

  • June 2020
  • Region: Global
  • TechSci Research
  • ID: 5067655
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Infection Surveillance Solutions Market is forecast to witness a CAGR of 16% and surpass $ 1 billion by 2025. Growth in the market can be attributed to rising healthcare expenditure, increasing number of surgeries, technological advancements in the field of healthcare IT, and growing awareness and accessibility to advanced healthcare facilities across the globe. Moreover, government policies and initiatives for the prevention of Healthcare-associated Infections (HAIs) are expected to continue boosting the adoption of infection surveillance solutions, globally.

The Global Infection Surveillance Solutions Market can be segmented based on product, infection type, end-user and region. In terms of product, the market is bifurcated into Software and Service. In 2019, the software segment dominated the market, primarily due to higher adoption of infection surveillance software by healthcare facilities. The demand for software is higher than services due to technological advancements they offer for efficient management of patient data, analysis and interpretation.

Based on infection type, the market can be segmented into blood stream, urinary tract, surgical site and others. Urinary tract infection dominates the infection type segment, followed by surgical site and blood stream segments. In terms of end-user, infection surveillance solutions market is segmented into hospitals & clinics, long term care facilities, ambulatory surgical centers and specialty centers. Hospitals & clinics are dominating the global market due to the high rate of admission of patients, increasing infections, and rise in the duration of patients staying at the hospitals.

Regionally, North America is the largest market for infection surveillance solutions and is expected to continue its dominance during the forecast period due to better healthcare facilities and higher awareness among patients about better healthcare services. Additionally, presence of major companies, continuous progress in healthcare settings and expansion of healthcare IT infrastructure are also driving the infection surveillance solutions market in this region. Asia Pacific is also expected to present lucrative opportunities in the coming years owing to the increasing efforts to avert HAIs and to improve overall healthcare facilities across the region.

Years considered for this report:
  • Historical Years: 2014-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:
  • To analyze and forecast the market size of the Global Infection Surveillance Solutions Market.
  • To classify and forecast the Global Infection Surveillance Solutions Market based on product, infection type, end-user, and regional distribution.
  • To identify major drivers & challenges for the Global Infection Surveillance Solutions Market
  • To identify major emerging trends of the Global Infection Surveillance Solutions Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Infection Surveillance Solutions Market.
  • To identify and profile major companies operating in the Global Infection Surveillance Solutions Market.

To analyze and forecast the Global Infection Surveillance Solutions Market, both top down and bottom up approaches have been used. Multiple employees from several healthcare companies have been interviewed through telephonic conversations to extract and verify the information. A brief study of the major players operating in infection surveillance solutions market was conducted globally, which included the analysis of information such as technological advancements in the field of healthcare IT, followed by the detailed estimated investments in upcoming years in healthcare infrastructure, government funding and expenditure for the development of healthcare IT solution and various healthcare reforms and initiatives in different countries. Moreover, detailed and in-depth scrutiny of information was done to understand each policy or external or internal factor which could increase or decrease the demand for infection surveillance solutions globally.

Various secondary sources such as company websites, Annual Reports, White Papers, Investor Presentation, News Articles, Associations, were also studied.

Key Target Audience:
  • Infection surveillance solutions market players and other stakeholders
  • Major end-users
  • Organizations, forums and alliances related to healthcare industry
  • Government bodies such as regulating authorities and policy makers
  • Market research and consulting firms

The study is essential in delivering useful information to the industry stakeholders such as providers, vendors and end-users. The report also provides useful insights about which market segments should be targeted over the coming years in order to strategize investments and capitalize on the growth opportunities.

Report Scope:
In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories in addition to the industry trends which have also been detailed below:

Market, by Product:
  • Software
  • Web/Cloud Based
  • On-premise Based
  • Service
  • Product Support & Maintenance Services
  • Training & Consulting Services
  • Implementation Services

Market, by Infection Type:
  • Surgical Site
  • Urinary Tract
  • Blood Stream
  • Others

Market, by End-User:
  • Hospitals & Clinics
  • Long-term Care Facilities
  • Ambulatory Surgical Centers
  • Specialty Centers

Market, by Region:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Voice of Customer: Monitor Safety, Identification of high-risk patients, and identification of care gaps for patients are the major factors affecting decision related to infection surveillance solutions for various users in the Global Infection Surveillance Solutions Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary4. Voice of Customer
5. Global Infection Surveillance Solutions Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Software (Web/Cloud Based & On-premise Based) vs. Service (Product Support & Maintenance Services, Training & Consulting Services, and Implementation Services)
5.2.2. By Infection Type (Surgical Site Infection, Urinary Tract Infection, Blood Stream Infection and Others)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Centers, Long-term Care Facilities)
5.2.4. By Region
5.2.5. By Company (2019)
5.3. Product Market Map
6. Asia-Pacific Infection Surveillance Solutions Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Infection Type
6.2.3. By End User
6.2.4. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Infection Surveillance Solutions Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Infection Type
6.3.1.2.3. By End User
6.3.2. India Infection Surveillance Solutions Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Infection Type
6.3.2.2.3. By End User
6.3.3. Japan Infection Surveillance Solutions Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Infection Type
6.3.3.2.3. By End User
6.3.4. South Korea Infection Surveillance Solutions Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product
6.3.4.2.2. By Infection Type
6.3.4.2.3. By End User
6.3.5. Rest of APAC Infection Surveillance Solutions Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product
6.3.5.2.2. By Infection Type
6.3.5.2.3. By End User
7. Europe Infection Surveillance Solutions Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Infection Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Infection Surveillance Solutions Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Infection Type
7.3.1.2.3. By End User
7.3.2. Italy Infection Surveillance Solutions Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Infection Type
7.3.2.2.3. By End User
7.3.3. Spain Infection Surveillance Solutions Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Infection Type
7.3.3.2.3. By End User
7.3.4. France Infection Surveillance Solutions Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Infection Type
7.3.4.2.3. By End User
7.3.5. United Kingdom Infection Surveillance Solutions Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Infection Type
7.3.5.2.3. By End User
7.3.6. Rest of Europe Infection Surveillance Solutions Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Product
7.3.6.2.2. By Infection Type
7.3.6.2.3. By End User
8. North America Infection Surveillance Solutions Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Infection Type
8.2.3. By End User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Infection Surveillance Solutions Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Infection Type
8.3.1.2.3. By End User
8.3.2. Mexico Infection Surveillance Solutions Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Infection Type
8.3.2.2.3. By End User
8.3.3. Canada Infection Surveillance Solutions Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Infection Type
8.3.3.2.3. By End User
9. South America Infection Surveillance Solutions Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Infection Type
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Infection Surveillance Solutions Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Infection Type
9.3.1.2.3. By End User
9.3.2. Argentina Infection Surveillance Solutions Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Infection Type
9.3.2.2.3. By End User
9.3.3. Colombia Infection Surveillance Solutions Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Infection Type
9.3.3.2.3. By End User
9.3.4. Rest of South America Infection Surveillance Solutions Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Infection Type
9.3.4.2.3. By End User
10. Middle East and Africa Infection Surveillance Solutions Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Infection Type
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. Saudi Arabia Infection Surveillance Solutions Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Infection Type
10.3.1.2.3. By End User
10.3.2. UAE Infection Surveillance Solutions Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Infection Type
10.3.2.2.3. By End User
10.3.3. South Africa Infection Surveillance Solutions Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Infection Type
10.3.3.2.3. By End User
10.3.4. Rest of MEA Infection Surveillance Solutions Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Infection Type
10.3.4.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Becton, Dickinson and Company
13.2. Baxter International Inc
13.3. Wolters Kluwer NV
13.4. Premier Inc.
13.5. Gojo Industries
13.6. BioVigil Healthcare Systems Inc
13.7. Medexter Healthcare GmbH
13.8. Koninklijke Philips NV
13.9. PeraHealth
13.10. Deb Group Ltd.
13.11. Cerner Corporation
14. Strategic Recommendations
(Note: The companies list can be customized based on the client requirements.)
List of Figures
Figure 1: Global Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 2: Global Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 3: Global Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 4: Global Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 5: Global Infection Surveillance Solutions Market Share, By Region, 2019 & 2025F
Figure 6: Global Infection Surveillance Solutions Market Share, By Company, 2019
Figure 7: North America Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 8: North America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 9: North America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 10: North America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 11: North America Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
Figure 12: US Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 13: US Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 14: US Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 15: US Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 16: Canada Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 17: Canada Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 18: Canada Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 19: Canada Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 20: Mexico Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 21: Mexico Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 22: Mexico Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 23: Mexico Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 24: APAC Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 25: APAC Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 26: APAC Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 27: APAC Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 28: APAC Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
Figure 29: China Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 30: China Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 31: China Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 32: China Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 33: India Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
Figure 34: India Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 35: India Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 36: India Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 37: Japan Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 38: Japan Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 39: Japan Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 40: Japan Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 41: South Korea Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 42: South Korea Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 43: South Korea Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 44: South Korea Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 45: Rest of APAC Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 46: Rest of APAC Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 47: Rest of APAC Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 48: Rest of APAC Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 49: Europe Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 50: Europe Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 51: Europe Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 52: Europe Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 53: Europe Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
Figure 54: Germany Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 55: Germany Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 56: Germany Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 57: Germany Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 58: Italy Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 59: Italy Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 60: Italy Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 61: Italy Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 62: France Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 63: France Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 64: France Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 65: France Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 66: Spain Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 67: Spain Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 68: Spain Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 69: Spain Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 70: UK Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 71: UK Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 72: UK Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 73: UK Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 74: Rest of Europe Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 75: Rest of Europe Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 76: Rest of Europe Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 77: Rest of Europe Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 78: South America Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 79: South America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 80: South America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 81: South America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 82: South America Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
Figure 83: Brazil Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 84: Brazil Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 85: Brazil Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 86: Brazil Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 87: Argentina Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 88: Argentina Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 89: Argentina Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 90: Argentina Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 91: Colombia Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 92: Colombia Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 93: Colombia Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 94: Colombia Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 95: Rest of South America Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 96: Rest of South America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 97: Rest of South America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 98: Rest of South America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 99: Middle East & Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 100: Middle East & Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 101: Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 102: Middle East & Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 103: Middle East & Africa Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
Figure 104: Saudi Arabia Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 105: Saudi Arabia Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 106: Saudi Arabia Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 107: Saudi Arabia Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 108: UAE Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 109: UAE Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 110: UAE Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 111: UAE Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 112: South Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 113: South Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 114: South Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 115: South Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
Figure 116: Rest of Middle East & Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
Figure 117: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
Figure 118: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
Figure 119: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
List of Tables
Table 1: Global HealthCare Regulatory Initiatives and Policies, By Region/Country

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Baxter International Inc
  • Wolters Kluwer NV
  • Premier Inc.
  • Gojo Industries
  • BioVigil Healthcare Systems Inc
  • Medexter Healthcare GmbH
  • Koninklijke Philips NV
  • PeraHealth
  • Deb Group Ltd.
  • Cerner Corporation